Migraine with aura

光环 皮质扩散性抑郁症 先兆偏头痛 心理学 偏头痛 医学 冲程(发动机) 精神科 机械工程 工程类
作者
Christian Lucas
出处
期刊:Revue Neurologique [Elsevier BV]
卷期号:177 (7): 779-784 被引量:49
标识
DOI:10.1016/j.neurol.2021.07.010
摘要

Around 15% to one-third of migraineurs experience aura. Aura is a fully reversible focal neurological phenomenon involving visual, sensory, speech, and/or motor symptoms that develops gradually and usually precedes the headache phase. The pivotal role of cortical spreading depression (CSD) as a mechanism underlying aura has been widely supported by a large body of studies. The diagnosis is based on the International Headache Classification Disorders III edition criteria. Aura is characterized by gradual development, duration of each symptom no longer than one hour, a mix of positive and negative features, and complete reversibility. Visual aura is the most common type of aura, occurring in over 90% of patients. When aura symptoms are multiple, they usually follow one another in succession, beginning with visual, then sensory, then aphasic; but the reverse and other orders have been noted. The accepted duration for most aura symptoms is one hour, but motor symptoms, which are rare, are often longer lasting. When a patient experiences for the first time a possible aura phase it's sometimes difficult to know if there was gradual or brutal onset of the symptoms. If the patient has no visual aura symptoms or simultaneous neurological symptoms, or presents neurological symptoms corresponding to a cerebral vascular territory, emergency exploration of a possible transient ischemic attack is necessary. Long duration (greater than one hour) of what may or may not be an aura phase, late onset of aura, or a dramatic increase in aura attacks should also be explored. The relative risk of ischemic stroke is significantly increased in migraine with aura. Combined hormonal contraception with estrogens significantly increases the risk of stroke in women with migraine with aura. It is recommended to start non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin as soon as possible during the aura phase, not to treat the aura, but to avoid or to diminish the headache phase. In case of failure of NSAIDs or aspirin it is recommended to use a triptan when the headache begins. The prophylactic treatments for migraine with aura are those used in migraine without aura based on very few randomized clinical trials specifically dedicated to migraine with aura.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
penxyy应助lingzhi采纳,获得20
1秒前
2秒前
beauty_bear完成签到,获得积分10
2秒前
尘香如故完成签到 ,获得积分10
3秒前
Aaaaguo完成签到 ,获得积分10
4秒前
万能图书馆应助Error404采纳,获得10
5秒前
5秒前
沉静丹寒发布了新的文献求助10
5秒前
aaa发布了新的文献求助10
6秒前
霍明轩完成签到 ,获得积分10
8秒前
8秒前
大力的灵雁应助LXY采纳,获得10
8秒前
fengl完成签到,获得积分10
9秒前
jelly完成签到,获得积分10
11秒前
阳光代芙发布了新的文献求助10
12秒前
yujie完成签到,获得积分10
12秒前
14秒前
14秒前
拒绝去偏旁完成签到 ,获得积分10
15秒前
感谢1872512转发科研通微信,获得积分50
15秒前
wujuan1606完成签到 ,获得积分10
16秒前
橘x应助yujie采纳,获得30
16秒前
欧阳蔚应助闪闪盼芙采纳,获得10
17秒前
18秒前
zz发布了新的文献求助10
18秒前
mjk发布了新的文献求助10
19秒前
19秒前
Focus完成签到,获得积分10
19秒前
20秒前
21秒前
感谢AaaPeii转发科研通微信,获得积分50
21秒前
21秒前
科研通AI6.2应助YuhangLiu采纳,获得10
22秒前
TAZIA发布了新的文献求助10
22秒前
zzz发布了新的文献求助10
22秒前
jz完成签到,获得积分10
23秒前
naych发布了新的文献求助10
23秒前
Roni发布了新的文献求助200
23秒前
无花果应助Linden_bd采纳,获得30
24秒前
andylue完成签到,获得积分10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 2000
Digital Twins of Advanced Materials Processing 2000
Social Cognition: Understanding People and Events 1200
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6036841
求助须知:如何正确求助?哪些是违规求助? 7756755
关于积分的说明 16215982
捐赠科研通 5182881
什么是DOI,文献DOI怎么找? 2773678
邀请新用户注册赠送积分活动 1756929
关于科研通互助平台的介绍 1641299